Evidence map›Paper›PMID 28225188›Full record

Trial reportHeadache2017

Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial.

Catherine Buettner, Agustin Melo-Carrillo, Rami Burstein

Abstract readClinical TrialLetter
In one paragraph

Trial report in Headache, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catherine BuettnerDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Agustin Melo-CarrilloDepartment of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Rami BursteinDepartment of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Photophobia during migraine: sensory, autonomic and emotional responses to lightR37NS079678 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BURSTEIN, RAMI · 2012 to 2018
$3.1M
Cortical Mechanisms of Headache: Beyond CSDR01NS094198 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BURSTEIN, RAMI · 2016 to 2020
$1.9M
Migraine pathophysiology: neural basis of photophobiaR01NS069847 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BURSTEIN, RAMI · 2010 to 2014
$1.9M
NCATS NIH HHS UL1 TR001102NINDS NIH HHS R01 NS069847NINDS NIH HHS R01 NS094198NINDS NIH HHS R37 NS079678
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cyclooxygenase InhibitorsDiclofenacHyperalgesiaMigraine DisordersAdolescentAdultFemaleHumansMiddle AgedPain MeasurementProspective StudiesSkinTreatment OutcomeYoung AdultCyclooxygenase InhibitorsDiclofenac

Identifiers

PMID28225188
PMCPMC7181471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.